ReportPlus delivers detailed and graphical reports on medicines usage and costs for hospitals (using the JAC system) via a simple interface - providing pharmacy and finance departments with access to core clinical and financial reports, as well as detailed information for recharging PCTs and meeting Care Quality Commission (CQC) requirements for the hospital star rating system. ReportPlus not only reduces the time to complete complex reporting tasks but also allows finance departments to review fiscal data without Pharmacy's intervention.
According to The Association of the British Pharmaceutical Industry (ABPI), the UK spent £11 billion on medicines in 2008; making medicine stocks the 2nd largest expenditure budget in a hospital after staff costs. Add to this the cost of the many man-hours spent managing and auditing medicines across an NHS Trust and the value of high quality medicines reporting quickly escalates.
Many hospitals are now collecting large amounts of medicines usage data through their pharmacy departments. However, they often lack a combination of easy access to this information, time to extract and organise it, and available expertise needed to interpret the charts and figures; allowing potential opportunities for cost savings (and making medicines therapies more effective) to go unnoticed.
Colin Richman, a former clinical pharmacist who led the development team, comments, "While there are clear incentives to monitor and analyse medicines data, few hospitals would choose to divert clinical experts away from front-line patient care to perform this time consuming yet necessary work. These issues are easily overcome through the use of ReportPlus, which presents critical but complex information via a simple user interface.
"Once pharmacists have this vital data at their fingertips, they are in a position to make informed decisions and help manage their hospital's costs far more effectively. The clinical review element also creates the opportunity for in depth analysis of, for example, cost modelling alternate therapies or working with microbiologists on drugs policy for infection control - helping to shape future best practice."
Andrew Duncan, Chief Pharmacist at The Royal Bournemouth Hospital was involved with the beta testing for ReportPlus. He comments, "Creating a positive patient experience is a fundamental objective of the NHS. So, anything that enables clinicians to spend more time with patients and less time carrying out administrative tasks, without compromising, in this instance, medicines usage and cost reporting ability, is to be welcomed.
"ReportPlus has the potential to provide clinical directorates with pertinent and timely information that will assist them to make decisions concerning appropriate medication cost and provision. The module also makes sharing information with relevant stakeholders straightforward and provides a holistic view of the entire medicines budget."
The key benefits of ReportPlus include:
- Improvement of access to financial and clinical data.
- Improved ability to manage drug costs.
- Speeds up the provision of Government required information.
- Improved ability to recharge drug costs from other organisations.
- Saves finance departments' time spent budget monitoring.
- Identifies spend hotspots (by month, drug or cost centre).
- Improves ability to identify other issues and risks to the organisation.
- Aids practice change through accessible and accurate clinical data.
- Simple distribution of reports to clinical and financial stakeholders.
- Antibiotic and other drug trend monitoring using the WHO DDD methodology
Clinical review of medicine usage can be generated easily through ReportPLUS. Key areas of monitoring practice change, implementation of guidance and reviewing antibiotic prescribing can all be generated from the system and data can be exported to Excel for further analysis if required. Cost benefits of alternative therapies can be simply modelled through the user interface based on the hospital's usage and costs. The DDD methodology embedded in the system also provides users with a recognised method for analysing drug usage at drug or therapeutic level e.g. antibiotics. In summary the features provided in ReportPLUS open a window to patterns of medicines use in the hospital allowing for accurate monitoring and better decision making.
About JAC Computer Services
JAC Computer Services Ltd (JAC) is the leading supplier of medicines management solutions to the NHS as well as to key sites in Ireland and South Africa. JAC's UK user-base now accounts for around half of all NHS trusts in England as well as sites in Scotland, Wales and Northern Ireland.
JAC provides pharmacy stock control, e-prescribing and medicines administration as a single integrated solution along with associated services. JAC is also the exclusive distributor in the UK and Ireland of ServeRx ward-based automation technologies for medicines and medical equipment.
The JAC solution for E-Prescribing and Medicines Administration (EPMA) includes integrated in-patient, out-patient and discharge prescribing with decision support for clinical checking on allergies, drug-drug interactions and therapeutic duplicates. In addition EPMA supports medicines administration recording and can be used at the patient's bedside by doctors, nurses and other clinicians.
In June 1996, JAC was acquired by Mediware Information Systems, a global provider of clinical software systems for healthcare. Mediware is publicly traded on the NASDAQ exchange in the United States (NASDAQ: MEDW) and has more than 1400 institutions worldwide using its blood and medicines management software products.